FEATURED COMPANIES
- Bag Healthcare
- Biofortuna
- Caredx
- Fujirebio
- Histogenetics
- Immucor
- MORE
The HLA typing market is projected to grow at a CAGR of 5.9% during the forecast period.
Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research.
Reagents & consumables accounted for the largest market share in 2019.
Based on product and service, the HLA typing market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the HLA typing market in 2019. This can be attributed to the growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets.
The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019.
On the basis of technology, the HLA typing market is segmented into molecular and non-molecular assay technologies. The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019. The growth of this segment is attributed to their benefits over non-molecular assays, such as low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis.
The diagnostic applications segment accounted for the largest share of the HLA typing market in 2019.
Based on application, the HLA typing market is segmented into diagnostic and research applications. The diagnostic applications segment dominates the HLA typing market. This is attributed to technological advancements in molecular assay techniques, the increasing adoption of molecular assay procedures for pathogen encounter detection and histocompatibility cross-matching, and the growing incidence of chronic and infectious diseases.
The commercial service providers segment accounted for the largest share of the HLA typing market in 2019.
The HLA typing market, by end user, is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the HLA typing market due to the ongoing rapid modernization and adoption of automation in HLA typing, growing outsourcing of R&D activities to said providers, and the increasing consolidation of diagnostic laboratories.
North America accounted for the largest share of the global HLA typing market in 2019.
The HLA typing market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global HLA typing market in 2019. This is majorly attributed to the high adoption of advanced diagnostic technologies, increasing prevalence of target diseases in the US and Canada, and technological advancements. The rising geriatric population and growing funding and support for research are other major factors driving the growth of this regional segment.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (42%), Tier 2 (28%), and Tier 3 (30%)
- By Designation: C-level (76%), Director-level (10%), and Others (14%)
- By Region: North America (40%), Europe (30%), APAC (22%), LATAM (6%), and the MEA (2%)
The major players operating in the HLA typing market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Immucor, Inc. (US), CareDx (US), Becton, Dickinson and Company (US), and Hologic (US).
Research Coverage
This report studies the HLA typing market based on product and service, technology, applications, end user, and region. The report also studies the major factors affecting market growth, such as drivers, restraints, opportunities, and challenges. In addition, it analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions.
Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.
FEATURED COMPANIES
- Bag Healthcare
- Biofortuna
- Caredx
- Fujirebio
- Histogenetics
- Immucor
- MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Major Market Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Procedure-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
4 Premium Insights
4.1 HLA Typing Market: Market Overview
4.2 Global Market Breakdown, By Product & Service
4.3 Market, By Technology
4.4 Market, By Application
4.5 Market, By End User
4.6 Geographic Snapshot of the HLA Typing Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Organ Transplantation Procedures
5.2.1.2 Technological Advancements in the Field of HLA Typing
5.2.1.3 Increasing Public-Private Funding for Research
5.2.1.4 Increasing Prevalence of Infectious & Non-Infectious Diseases
5.2.2 Restraints
5.2.2.1 High Cost of HLA Typing Products
5.2.2.2 Limited Reimbursements for Target Procedures
5.2.3 Opportunities
5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing
5.2.3.2 Increasing Public Awareness About Transplantation
5.2.4 Challenges
5.2.4.1 Supply-Demand Gap Between the Number of Organ Donors and Organs Required Annually
5.2.4.2 Dearth of Skilled Professionals for Performing HLA Typing
6 HLA Typing Market, By Product & Service
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Expanding Applications of Molecular Assay Techniques Like PCR and NGS in HLA Typing Will Aid Market Growth
6.3 Instruments
6.3.1 Technological Advancements and Increasing Awareness Support the Adoption of Instruments
6.4 Software & Services
6.4.1 Automation and Digitization in Lab Procedures and Rising Demand for Specialized Equipment are Driving Market Growth
7 HLA Typing Market, By Technology
7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 PCR-Based Molecular Assays
7.2.1.1 Sequence-Specific Primer-PCR
7.2.1.1.1 Expanding Distribution Networks of Key PCR Manufacturers to Support Market Growth
7.2.1.2 Sequence-Specific Oligonucleotide-PCR
7.2.1.2.1 High Demand of Sso-PCR is Due to Its Benefits in Donor-Recipient Cross-Matching and Disease Diagnosis
7.2.1.3 Real-Time PCR
7.2.1.3.1 Growing End-User Preference for Genome-Based Molecular Diagnostics has Supported the Demand for Real-Time PCR
7.2.1.4 Other PCR-Based Molecular Assays
7.2.2 Sequencing-Based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.1.1 Rising End-User Preference for Low-Cost and Efficient Dna Sequencing Technology Drives Market Growth
7.2.2.2 Next-Generation Sequencing
7.2.2.2.1 High Scalability, Low Turnaround Time, and High-Throughput Capabilities have Fueled the Use of NGS
7.2.2.3 Other Sequencing-Based Molecular Assays
7.3 Non-Molecular Assay Technologies
7.3.1 Rapid Adoption of Molecular Assay Techniques Will Hamper Market Growth in This Segment
8 HLA Typing Market, By Application
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Donor-Recipient Cross-Matching
8.2.1.1 Need for Histocompatibility Cross-Matching in Organ Transplantation Drives Market Growth
8.2.2 Infectious Disease Testing
8.2.2.1 Growing Burden of Infectious Diseases is Likely to Aid Market Growth
8.2.3 Cancer Diagnosis & Prevention
8.2.3.1 Clinical Evidence for the Success of HLA Typing in Cancer Diagnostics Will Positively Affect This Market
8.2.4 Transfusion Therapy
8.2.4.1 Increasing Evidence for the Success of HLA Typing in Blood Transfusion is A Key Contributor to Market Growth
8.2.5 Other Diagnostic Applications
8.3 Research Applications
8.3.1 Rising Funding for Research and Expanding Applications of HLA Typing are Driving Market Growth
9 HLA Typing Market, By End User
9.1 Introduction
9.2 Commercial Service Providers
9.2.1 Rapid Modernization and Automation in HLA Typing to Support Market Growth in This Segment
9.3 Hospitals & Transplant Centers
9.3.1 High Purchasing Power of Hospitals has Ensured Strong Adoption of Instruments, Reagents, and Consumables
9.4 Research Laboratories & Academic Institutes
9.4.1 Rising Government Support for Research Related to Cancer Diagnosis Will Propel Market Growth
10 HLA Typing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Technological Advancements in the Field of HLA Typing Will Drive Market Growth in the US
10.2.2 Canada
10.2.2.1 Rising Incidence of Cancer Will Support the Adoption of Genomic Research in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted for the Largest Share of the European Market
10.3.2 UK
10.3.2.1 Rising Prevalence of Autoimmune Diseases Drives Market Growth in the UK
10.3.3 France
10.3.3.1 Increasing Organ Rejection Rate Drives the Need for HLA Typing in France
10.3.4 Italy
10.3.4.1 Italy’s Healthcare Sector has Witnessed Sluggish Growth in Recent Years
10.3.5 Spain
10.3.5.1 Rising Number of Solid-Organ Transplantation Procedures to Drive Market Growth in Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Supportive Government Regulations Will Drive Market Growth in China
10.4.2 India
10.4.2.1 Increasing Number of Transplantation Procedures Drives Market Growth in India
10.4.3 Japan
10.4.3.1 Limited Research and Exploration in the Diagnostics Field to Limit the Adoption of HLA Procedures
10.4.4 Australia
10.4.4.1 Rising Prevalence of Coeliac Disease in Australia to Support the HLA Typing Market
10.4.5 South Korea
10.4.5.1 Expansion By Leading Market Players in South Korea Will Support Market Growth
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 Brazil Dominates the Latam Market
10.5.2 Mexico
10.5.2.1 Rising Medical Tourism to Support Market Growth in Mexico
10.5.3 Rest of Latam
10.6 Middle East and Africa
10.6.1 MEA Will Hold A Smaller Share and Grow at A Lesser Rate Than Major Regional Markets
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Key Product Launches and Approvals
11.3.2 Key Agreements and Collaborations
11.3.3 Key Acquisitions
11.3.4 Key Expansions
11.4 Competitive Leadership Mapping
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies
12 Company Profiles
(Business Overview, Products and Services Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 Thermo Fisher Scientific
12.2 Qiagen
12.3 Illumina
12.4 F. Hoffman-La Roche Limited
12.5 Bio-Rad Laboratories
12.6 Becton, Dickinson and Company
12.7 TBG Diagnostics
12.8 Fujirebio
12.9 Takara Bio
12.10 Caredx
12.11 Omixon
12.12 Immucor
12.13 Genome Diagnostics
12.14 Biofortuna
12.15 Creative Biolabs
12.16 Other Companies
12.16.1 Bag Healthcare
12.16.2 Histogenetics
12.16.3 Pacific Biosciences of California
12.16.4 BGI Genomics
12.16.5 Krishgen Biosystems
*Business Overview, Products and Services Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
List of Tables (158 Tables)
Table 1 Public-Private Investments and Research Grants for the Development of HLA Typing Products, 2015–2018
Table 2 Cost of Assays for Major NGS/PCR-Based Genomic Tests in Europe (As of 2017)
Table 3 HLA Typing Market, By Product & Service, 2017–2025 (USD Million)
Table 4 Market for Reagents & Consumables, By Region, 2017–2025 (USD Million)
Table 5 Market for Instruments, By Region, 2017–2025 (USD Million)
Table 6 Market for Software & Services, By Region, 2017–2025 (USD Million)
Table 7 Market, By Technology, 2017–2025 (USD Million)
Table 8 Market for Molecular Assay Technologies, By Type, 2017–2025 (USD Million)
Table 9 Market for Molecular Assay Technologies, By Product & Service, 2017–2025 (USD Million)
Table 10 Market for Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 11 Market for Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 12 Market for Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 13 Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 14 Market for PCR-Based Molecular Assays, By Product & Service, 2017–2025 (USD Million)
Table 15 Market for PCR-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 16 Market for PCR-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 17 Market for PCR-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 18 Market for Sequence-Specific Primer-PCR, By Region, 2017–2025 (USD Million)
Table 19 Market for Sequence-Specific Oligonucleotide-PCR, By Region, 2017–2025 (USD Million)
Table 20 HLA Typing Market for Real-Time PCR, By Region, 2017–2025 (USD Million)
Table 21 Market for Other PCR-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 22 Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 23 Market for Sequencing-Based Molecular Assays, By Product & Service, 2017–2025 (USD Million)
Table 24 Market for Sequencing-Based Molecular Assays, By Application, 2017–2025 (USD Million)
Table 25 Market for Sequencing-Based Molecular Assays, By End User, 2017–2025 (USD Million)
Table 26 Market for Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 27 Market for Sanger Sequencing, By Region, 2017–2025 (USD Million)
Table 28 Market for Next-Generation Sequencing, By Region, 2017–2025 (USD Million)
Table 29 Market for Other Sequencing-Based Molecular Assays, By Region, 2017–2025 (USD Million)
Table 30 Market for Non-Molecular Assay Technologies, By Product & Service, 2017–2025 (USD Million)
Table 31 Market for Non-Molecular Assay Technologies, By Application, 2017–2025 (USD Million)
Table 32 HLA Typing Market for Non-Molecular Assay Technologies, By End User, 2017–2025 (USD Million)
Table 33 Market for Non-Molecular Assay Technologies, By Region, 2017–2025 (USD Million)
Table 34 Market, By Application, 2017–2025 (USD Million)
Table 35 Market for Diagnostic Applications, By Type, 2017–2025 (USD Million)
Table 36 HLA Typing Market for Diagnostic Applications, By Region, 2017–2025 (USD Million)
Table 37 Market for Donor-Recipient Cross-Matching, By Region, 2017–2025 (USD Million)
Table 38 Market for Infectious Disease Testing, By Region, 2017–2025 (USD Million)
Table 39 Market for Cancer Diagnosis & Prevention, By Region, 2017–2025 (USD Million)
Table 40 Market for Transfusion Therapy, By Region, 2017–2025 (USD Million)
Table 41 HLA Typing Market for Other Diagnostic Applications, By Region, 2017–2025 (USD Million)
Table 42 Market for Research Applications, By Region, 2017–2025 (USD Million)
Table 43 Market, By End User, 2017–2025 (USD Million)
Table 44 Market for Commercial Service Providers, By Region, 2017–2025 (USD Million)
Table 45 Market for Hospitals & Transplant Centers, By Region, 2017–2025 (USD Million)
Table 46 HLA Typing Market for Research Laboratories & Academic Institutes, By Region, 2017–2025 (USD Million)
Table 47 Market, By Region, 2017–2025 (USD Million)
Table 48 North America: Market, By Country, 2017–2025 (USD Million)
Table 49 North America: Market, By Technology, 2017–2025 (USD Million)
Table 50 North America: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 51 North America: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 52 North America: HLA Typing Market, By Product & Service, 2017–2025 (USD Million)
Table 53 North America: Market, By Application, 2017–2025 (USD Million)
Table 54 North America: Market, By End User, 2017–2025 (USD Million)
Table 55 Solid Organ Transplantations Performed in the US, 2017–2018
Table 56 Target Diseases in the US, 2018
Table 57 Cancer Cases in the US By Organ (New Cases), 2017
Table 58 US: Market, By Technology, 2017–2025 (USD Million)
Table 59 US: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 60 US: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 61 Solid Organ Transplantations Performed in Canada, 2017–2018
Table 62 Target Disease in Canada, 2017
Table 63 Cancer Cases in Canada By Organ (New Cases), 2018
Table 64 Canada: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 65 Canada: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 66 Canada: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 67 Europe: Market, By Country, 2017–2025 (USD Million)
Table 68 Europe: Market, By Technology, 2017–2025 (USD Million)
Table 69 Europe: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 70 Europe: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 71 Europe: Market, By Product & Service, 2017–2025 (USD Million)
Table 72 Europe: Market, By Application, 2017–2025 (USD Million)
Table 73 Europe: Market, By End User, 2017–2025 (USD Million)
Table 74 Number of Organ Transplantations Performed in Germany, 2017–2018
Table 75 Target Disease in Germany, 2017
Table 76 Cancer Cases in Germany By Organ (New Cases), 2017
Table 77 Germany: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 78 Germany: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 79 Germany: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 80 Number of Organ Transplantations Performed in the UK, 2017–2018
Table 81 Target Disease in the UK, 2017
Table 82 Cancer Cases in the UK By Organ (New Cases), 2018
Table 83 UK: Market, By Technology, 2017–2025 (USD Million)
Table 84 UK: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 85 UK: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 86 Number of Organ Transplantations Performed in France, 2017–2018
Table 87 Cancer Cases in France By Organ (New Cases), 2018
Table 88 France: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 89 France: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 90 France: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 91 Italy: Market, By Technology, 2017–2025 (USD Million)
Table 92 Italy: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 93 Italy: HLA Typing Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 94 Spain: Market, By Technology, 2017–2025 (USD Million)
Table 95 Spain: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 96 Spain: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 97 RoE: Market, By Technology, 2017–2025 (USD Million)
Table 98 RoE: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 99 RoE: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 100 Asia Pacific: Market, By Country, 2017–2025 (USD Million)
Table 101 Asia Pacific: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 102 Asia Pacific: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 103 Asia Pacific: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 104 Asia Pacific: Market, By Product & Service, 2017–2025 (USD Million)
Table 105 Asia Pacific: Market, By Application, 2017–2025 (USD Million)
Table 106 Asia Pacific: Market, By End User, 2017–2025 (USD Million)
Table 107 Number of Organ Transplantations Performed in China, 2017–2018
Table 108 Cancer Cases in China By Organ (New Cases), 2018
Table 109 China: Market, By Technology, 2017–2025 (USD Million)
Table 110 China: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 111 China: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 112 Number of Organ Transplantations Performed in India, 2017–2018
Table 113 Cancer Cases in India By Organ (New Cases), 2018
Table 114 India: Market, By Technology, 2017–2025 (USD Million)
Table 115 India: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 116 India: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 117 Number of Organ Transplantations Performed in Japan, 2017–2018
Table 118 Cancer Cases in Japan By Organ (New Cases), 2018
Table 119 Japan: Market, By Technology, 2017–2025 (USD Million)
Table 120 Japan: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 121 Japan: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 122 Number of Organ Transplantations Performed in Australia, 2017–2018
Table 123 Cancer Cases in Australia By Organ (New Cases), 2018
Table 124 Australia: Market, By Technology, 2017–2025 (USD Million)
Table 125 Australia: HLA Typing Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 126 Australia: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 127 South Korea: Market, By Technology, 2017–2025 (USD Million)
Table 128 South Korea: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 129 South Korea: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 130 RoAPAC: Market, By Technology, 2017–2025 (USD Million)
Table 131 RoAPAC: HLA Typing Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 132 RoAPAC: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 133 Latam: Market, By Country, 2017–2025 (USD Million)
Table 134 Latam: Market, By Technology, 2017–2025 (USD Million)
Table 135 Latam: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 136 Latam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 137 Latam: Market, By Product & Service, 2017–2025 (USD Million)
Table 138 Latam: Market, By Application, 2017–2025 (USD Million)
Table 139 Latam: Market, By End User, 2017–2025 (USD Million)
Table 140 Solid Organ Transplantations Performed in the Brazil, 2017–2018
Table 141 Cancer Cases in Brazil By Organ (New Cases), 2018
Table 142 Brazil: Market, By Technology, 2017–2025 (USD Million)
Table 143 Brazil: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 144 Brazil: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 145 Solid Organ Transplantations Performed in Mexico, 2017–2018
Table 146 Cancer Cases in Mexico By Organ (New Cases), 2018
Table 147 Mexico: HLA Typing Market, By Technology, 2017–2025 (USD Million)
Table 148 Mexico: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 149 Mexico: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 150 RoLAtam: Market, By Technology, 2017–2025 (USD Million)
Table 151 RoLAtam: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 152 RoLAtam: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 153 MEA: Market, By Technology, 2017–2025 (USD Million)
Table 154 MEA: Market for PCR-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 155 MEA: Market for Sequencing-Based Molecular Assays, By Type, 2017–2025 (USD Million)
Table 156 MEA: Market, By Product & Service, 2017–2025 (USD Million)
Table 157 MEA: Market, By Application, 2017–2025 (USD Million)
Table 158 MEA: HLA Typing Market, By End User, 2017–2025 (USD Million)
List of Figures (33 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primaries: Global HLA Typing Market
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Market Size Estimation: Market
Figure 5 Data Triangulation Methodology
Figure 6 Market Share, By Product, 2019 vs 2025 (USD Million)
Figure 7 Market Share, By Application, 2019 vs 2025
Figure 8 Market, By Technology, 2019–2025 (USD Million)
Figure 9 ng Market, By End User
Figure 10 HLA Typing Market, By Region: Geographical Snapshot
Figure 11 Increasing Number of Organ Transplantation Procedures Across the Globe is Supporting the Growth of the Market
Figure 12 Reagents & Consumables Held the Largest Share of the Market
Figure 13 Molecular Assay Technologies Segment to Hold Largest Share of the Global Market
Figure 14 Diagnostic Applications Hold the Major Share of the Market, By Application
Figure 15 Commercial Service Providers Segment Will Register the Highest CAGR
Figure 16 China to Register the Highest CAGR During the Forecast Period
Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 North America: HLA Typing Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Product Launches and Enhancements Were the Key Growth Strategies Adopted By Market Players From 2016 to 2019
Figure 21 Thermo Fisher Scientific Dominates the Global HLA Typing Market, as of 2019
Figure 22 Market (Global): Competitive Leadership Mapping, 2019
Figure 23 Thermo Fisher Scientific: Company Snapshot (2018)
Figure 24 Qiagen: Company Snapshot (2018)
Figure 25 Illumina: Company Snapshot (2019)
Figure 26 F. Hoffman-La Roche Limited: Company Snapshot (2018)
Figure 27 Bio-Rad Laboratories: Company Snapshot (2018)
Figure 28 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 29 TBG Diagnostics Limited: Company Snapshot (2018)
Figure 30 Fujirebio: Company Snapshot (2016)
Figure 31 Takara: Company Snapshot (2019)
Figure 32 Caredx: Company Snapshot (2018)
Figure 33 Immucor: Company Snapshot (2016)
- Bag Healthcare
- Becton, Dickinson and Company
- BGI Genomics
- Biofortuna
- Bio-Rad Laboratories
- Caredx
- Creative Biolabs
- F. Hoffman-La Roche Limited
- Fujirebio
- Genome Diagnostics
- Histogenetics
- Illumina
- Immucor
- Krishgen Biosystems
- Omixon
- Pacific Biosciences of California
- Qiagen
- Takara Bio
- TBG Diagnostics
- Thermo Fisher Scientific
![Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024 - Product Image](http://www.researchandmarkets.com/product_images/8414/8414937_60px_jpg/isothermal_nucleic_acid_amplification_technologyinaat_market_by_product_assay_and_kit_system_application_infectious_disease_[hiv_influenza]_blood_screening_type_lamp_sda_nasba_hda_end_user_region_global_forecast_to_2024.jpg)
